Globus Medical (GMED) has been upgraded to a Zacks Rank #1 (Strong Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
Investors interested in Medical - Instruments stocks are likely familiar with Globus Medical (GMED) and Integer (ITGR). But which of these two stocks is more attractive to value investors?
Globus Medical NYSE: GMED reported second-quarter 2026 revenue of $789.6 million, up 6% from a year earlier, as growth in its spine and trauma businesses helped offset declines in enabling technologies and Nevro sales. The company reaffirmed its full-year revenue outlook while raising its adjusted earnings forecast, citing margin expansion and operating leverage in the first half.
| Health Care Equipment & Supplies Industry | Healthcare Sector | Keith W. Pfeil CEO | XETRA Exchange | US3795772082 ISIN |
| US Country | 6,000 Employees | - Last Dividend | - Last Split | 3 Aug 2012 IPO Date |
Globus Medical, Inc. is a prominent medical device company focused on innovating healthcare solutions for patients dealing with musculoskeletal disorders, serving both the United States and international markets. Since its inception in 2003, Globus Medical has been at the forefront of developing a wide range of medical devices aimed at improving the quality of life for patients suffering from a variety of conditions, including degenerative and congenital disorders, deformities, tumors, and trauma injuries. With its headquarters located in Audubon, Pennsylvania, Globus Medical has established a strong global presence, distributing its products through a mix of direct sales, distributor representatives, and independent sales agents.
Globus Medical, Inc. offers an extensive portfolio of products and solutions across multiple domains within the musculoskeletal treatment spectrum:
Apart from its direct contribution to improving patient outcomes with its products, Globus Medical also engages in the distribution of human cell, tissue, and cellular and tissue-based products, leveraging its extensive network to facilitate availability across its served markets.